Acufex Suretac Ixc Systems
Acufex Microsurgical
FDA Clearance Information
The Acufex Suretac IXC Systems was cleared through the FDA 510(k) pathway on April 26, 1994, by Acufex Microsurgical. It is classified as a Class 2 device under product code HRX.
What It Is
FDA-Cleared Indications
- The FDA record lists the indication as "Statement," without a complete indication statement in the supplied record.
- The device was cleared through the 510(k) pathway as a Class II device under product code HRX.
Clinical Applications
Practical Considerations
- Confirm the complete FDA labeling and manufacturer instructions before clinical use; the supplied record does not include the actual indication statement.
- Do not assume compatibility with embolic agents, catheters, guidewires, delivery systems, or other accessories without verifying the device labeling.
- The available information does not establish the device's MRI safety status. Check current labeling for MR Safe, MR Conditional, or MR Unsafe information.
- Use only according to the cleared labeling, including any specified patient-selection criteria, anatomical limitations, handling instructions, and contraindications.
- The supplied record does not identify device dimensions, available sizes, materials, sterilization method, or single-use status.
Frequently Asked Questions
What is Acufex Suretac IXC Systems used for?
The device is used for uterine fibroid embolization, a procedure to treat symptomatic uterine fibroids by reducing their blood supply.
What specialties typically use this device?
Interventional radiologists and gynecologists specializing in minimally invasive procedures commonly use this device.
What are the FDA-cleared indications?
The device is indicated for use in uterine fibroid embolization, targeting patients with symptomatic uterine fibroids.